A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19

NCT04640194 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Distress Syndrome

Interventions

PROCEDURE: Standard of care
DRUG: Alteplase low dose
DRUG: Alteplase high dose

Sponsor

Boehringer Ingelheim